Patents by Inventor Isabelle A. Gaultier

Isabelle A. Gaultier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160333404
    Abstract: The present invention features therapies for the treatment of HCV comprising direct-acting antiviral agents. Preferably, the treatment is administered to an HCV-infected patient who has been tested to determine expression levels of microRNAs such as miR-122 or miR-21. In one aspect, the therapies comprise administering one or more direct acting antiviral agents and, optionally ribavirin, to a subject with HCV infection. For example, the therapies comprise administering to the subject effective amounts of therapeutic agent 1, therapeutic agent 2, an inhibitor of cytochrome P450 (e.g., ritonavir), and ribavirin.
    Type: Application
    Filed: December 2, 2014
    Publication date: November 17, 2016
    Inventors: Barry M. Bernstein, Isabelle A. Gaultier, Daniel E. Cohen, Jeffrey F. Waring, Stephen J. Abel, Emily O. Dumas
  • Patent number: 9044480
    Abstract: The present invention features methods of using Compound I to suppress HCV mutants, treat treatment-experienced HCV patients, and treat HCV patients having non-CC IL28B rs12979860 genotype.
    Type: Grant
    Filed: March 5, 2012
    Date of Patent: June 2, 2015
    Assignee: AbbVie Inc.
    Inventors: Tami Pilot-Matias, Isabelle A. Gaultier, Rakesh L. Tripathi, Christine A. Collins, Daniel E. Cohen, Barry M. Bernstein